Literature DB >> 3688314

Comparison of serologic tests for the diagnosis and follow-up of alveolar hydatid disease.

A P Lanier1, D E Trujillo, P M Schantz, J F Wilson, B Gottstein, B J McMahon.   

Abstract

Alveolar hydatid disease is a serious and often fatal condition caused by infection with the metacestode form of Echinococcus multilocularis. Sera of 21 patients with histologically confirmed disease were tested by an enzyme-linked immunosorbent assay (ELISA) using a semi-purified E. multilocularis antigen fraction (Em2) and by indirect hemagglutination (IHA) and double diffusion (DD5) tests using antigens prepared from E. granulosus cyst fluid. At diagnosis, sera from all 21 patients were positive by Em2 ELISA, 18 (86%) by IHA, and 5 (24%) by DD5. Em2 ELISA detected an antibody response earlier than IHA in 4 of 9 patients from whom sera were available before diagnosis. Following complete surgical resection, Em2 ELISA converted from positive to negative in serum of 2 of 3 patients, while IHA results did not change. Following incomplete resection, 14 of 15 patients tested remained positive by Em2 ELISA, while 12 remained positive by IHA. Of sera from 361 healthy persons from regions free of E. multilocularis, none were positive by Em2 ELISA, while 8% were positive by IHA. Of sera from 59 patients with non-echinococcal parasitic infections, none were positive by Em2 ELISA, while 31% were positive by IHA. Thus, in comparison with tests using E. granulosus antigens, Em2 ELISA appears to be more sensitive and specific for diagnosing AHD, useful on follow-up of resected patients, and positive earlier in the course of disease.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3688314     DOI: 10.4269/ajtmh.1987.37.609

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  6 in total

Review 1.  Hepatic echinococcosis: clinical and therapeutic aspects.

Authors:  Giuseppe Nunnari; Marilia R Pinzone; Salvatore Gruttadauria; Benedetto M Celesia; Giordano Madeddu; Giulia Malaguarnera; Piero Pavone; Alessandro Cappellani; Bruno Cacopardo
Journal:  World J Gastroenterol       Date:  2012-04-07       Impact factor: 5.742

2.  Improved primary immunodiagnosis of alveolar echinococcosis in humans by an enzyme-linked immunosorbent assay using the Em2plus antigen.

Authors:  B Gottstein; P Jacquier; S Bresson-Hadni; J Eckert
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

3.  Echinococcus multilocularis: parasite-specific humoral and cellular immune response subsets in mouse strains susceptible (AKR, C57B1/6J) or 'resistant' (C57B1/10) to secondary alveolar echinococcosis.

Authors:  B Gottstein; E Wunderlin; I Tanner
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

Review 4.  Molecular and immunological diagnosis of echinococcosis.

Authors:  B Gottstein
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

5.  Echinococcal disease in Alberta, Canada: more than a calcified opacity.

Authors:  Ali Somily; Joan L Robinson; Lilly J Miedzinski; Ravi Bhargava; Thomas J Marrie
Journal:  BMC Infect Dis       Date:  2005-05-17       Impact factor: 3.090

6.  The Alaska Area Specimen Bank: a tribal-federal partnership to maintain and manage a resource for health research.

Authors:  Alan J Parkinson; Thomas Hennessy; Lisa Bulkow; H Sally Smith
Journal:  Int J Circumpolar Health       Date:  2013-04-16       Impact factor: 1.228

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.